Skip to Main Content

Paper Details

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer.
Sci Adv
8
2022
Author NameAffiliation
Sirano Dhe-PaganonDana-Farber Cancer Institute, Harvard Medical School
Sirano Dhe-PaganonHarvard Medical School
  • 1 - 2

Datasets

Release 1.2